Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study.
Marder
Karen
K
D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D016022:Case-Control Studies; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D016001:Confidence Intervals; D000077265:Donepezil; D004311:Double-Blind Method; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008609:Mental Status Schedule; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D010880:Piperidines / Q000627:therapeutic use*; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil